Zolpidem Induced Hyponatremia: A Case Report

被引：3

作者：

Priya, Shanmuga S. ^{[1
]}

Britto, D. L. ^{[1
]}

Saravanan, T. ^{[2
]}

机构：

[1] PSG Inst Med Sci & Res, Dept Pharmacol, Coimbatore, Tamil Nadu, India

[2] PSG Inst Med Sci & Res, Dept Med, Coimbatore, Tamil Nadu, India

来源：

JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH | 2014年 / 8卷 / 09期

关键词：

Gabaa receptor; Hyponatremia; Insomnia; Siadh; Zolpidem;

D O I：

10.7860/JCDR/2014/10031.4901

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Zolpidem is a non-benzodiazepine hypnotic that acts by binding to (GABAA) receptor. This is a case report of a patient with chronic insomnia for which he had initially been receiving benzodiazepine hypnotic alprazolam and for the past three years, he had switched himself to non-benzodiazepine hypnotic, zolpidem and had progressively increased the dose to 20 mg. The patient presented with history of drowsiness, nausea and vomiting of short duration. Investigations revealed that the patient had hyponatremia. Decreased serum sodium, elevated urine sodium with normal urine osmolarity was detected. Therefore, we report this as a case of drug induced syndrome of inappropriate antidiuretic hormone (SIADH) as other likely causes were ruled out by appropriate investigations. The causality assessment was done according to the WHO scale and found to be "Probable".

引用

页码：HD03 / HD04

页数：2

共 10 条

[1]

BESSET A, 1995, DRUG EXP CLIN RES, V21, P161

[2]

Damm J, 2010, WORLD J BIOL PSYCHIA, V11, P516, DOI [10.1080/15622970902960897, 10.3109/15622970903369973]

[3] Comparative efficacy of newer hypnotic drugs for the short-term management of insomnia:: a systematic review and meta-analysis [J].

Dündar, Y ;

Dodd, S ;

Strobl, J ;

Boland, A ;

Dickson, R ;

Walley, T .

HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2004, 19 (05) :305-322

[4] INAPPROPRIATE SECRETION OF ANTIDIURETIC-HORMONE ASSOCIATED WITH LORAZEPAM [J].

ENGEL, WR ;

GRAU, A .

BRITISH MEDICAL JOURNAL, 1988, 297 (6652) :858-858

[5] GAMMA-AMINOBUTYRIC ACIDA RECEPTOR ALPHA-5-SUBUNIT CREATES NOVEL TYPE-II BENZODIAZEPINE RECEPTOR PHARMACOLOGY [J].

PRITCHETT, DB ;

SEEBURG, PH .

JOURNAL OF NEUROCHEMISTRY, 1990, 54 (05) :1802-1804

[6] CLINICAL PHARMACOKINETICS AND PHARMACODYNAMICS OF ZOLPIDEM - THERAPEUTIC IMPLICATIONS [J].

SALVA, P ;

COSTA, J .

CLINICAL PHARMACOKINETICS, 1995, 29 (03) :142-153

[7] DISCRIMINATIVE STIMULUS EFFECTS OF OMEGA (BZ) RECEPTOR LIGANDS - CORRELATION WITH INVIVO INHIBITION OF [H-3] FLUMAZENIL BINDING IN DIFFERENT REGIONS OF THE RAT CENTRAL-NERVOUS-SYSTEM [J].

SANGER, DJ ;

BENAVIDES, J .

PSYCHOPHARMACOLOGY, 1993, 111 (03) :315-322

[8] Effect of α subunit on allosteric modulation of ion channel function in stably expressed human recombinant γ-aminobutyric acidA receptors determined using 36Cl ion flux [J].

Smith, AJ ;

Alder, L ;

Silk, J ;

Adkins, C ;

Fletcher, AE ;

Scales, T ;

Kerby, J ;

Marshall, G ;

Wafford, KA ;

Mckernan, RM ;

Atack, JR .

MOLECULAR PHARMACOLOGY, 2001, 59 (05) :1108-1118

[9] HYPONATREMIA AND THE SYNDROME OF INAPPROPRIATE ANTIDIURETIC-HORMONE SECRETION (SIADH) INDUCED BY PSYCHOTROPIC-DRUGS [J].

SPIGSET, O ;

HEDENMALM, K .

DRUG SAFETY, 1995, 12 (03) :209-225

[10] Adverse drug reaction and causality assessment scales [J].

Zaki, Syed Ahmed .

LUNG INDIA, 2011, 28 (02) :152-153

← 1 →